Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH 2017 | New treatments for AML using inhibitors

Francesco Lo-Coco • 5 Oct 2017
ESH 2017
Acute Myeloid Leukemia General

This is an exciting time for acute myeloid leukemia (AML) treatment, with multiple new therapies being investigated currently. In this interview, Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy discusses recent research using inhibitors for the treatment of AML. This video was recorded at the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH).

More from Francesco Lo-Coco

3:58
Targeted treatments for AML: the revolution
Francesco Lo-Coco • 10 Dec 2017
3:41
Advancements in APL treatment: oral ATO, MRD and treatment objectives
Francesco Lo-Coco • 10 Dec 2017
2:06
APL: getting the perfect picture
Francesco Lo-Coco • 10 Dec 2017
1:57
The standardization of molecular diagnostics for myeloid diseases in Italy
Francesco Lo-Coco • 5 Oct 2017

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals